HSD17B3 and Familial prostate cancer: We identified the β-hydroxysteroid-dehydrogenases HSD17B1 and HSD17B3 to be significantly up-regulated in metastatic compared to non-metastatic prostate cancer; they also correlated with the intensity of SR-BI expression (Fig. 4a–h).